Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway

Pharmacological Research

Volumn 65, Issue 3, 2012, Pages 275-284

  Cantoni, Silvia ^a,b,c   Cavallini, Claudia ^a,b   Bianchi, Francesca ^a,b   Bonavita, Francesca ^a,b   Vaccari, Valentina ^a,b   Olivi, Elena ^a,b,c   Frascari, Irene ^a,b   Tassinari, Riccardo ^a,b   Valente, Sabrina ^c   Lionetti, Vincenzo ^c,d,e   Ventura, Carlo ^a,b  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SCUOLA SUPERIORE SANT ANNA   (Italy)

^e CNR   (Italy)

Author keywords

Angiogenesis; Mesenchymal stem cell; Paracrine effects; Statin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; ROSUVASTATIN; SCATTER FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; MESENCHYMAL STEM CELL; PARACRINE SIGNALING; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANGIOGENESIS INDUCING AGENTS; CELLS, CULTURED; FEMALE; FLUOROBENZENES; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PLACENTA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINES; SIGNAL TRANSDUCTION; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84857041421     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.12.004     Document Type: Article

References (37)

1. J.K. Liao Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond lowdensity lipoprotein cholesterol Am J Cardiol 96 2005 24F 33F (Pubitemid 41207730)
2. Y. Kureishi, Z. Luo, I. Shiojima, A. Bialik, D. Fulton, and D.J. Lefer The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 2000 1004 1010
3. J. Llevadot, S. Murasawa, Y. Kureishi, S. Uchida, H. Masuda, and A. Kawamoto HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells J Clin Invest 108 2001 399 405 (Pubitemid 32730786)
4. S. Erbs, E.B. Beck, A. Linke, V. Adams, S. Gielen, and N. Kränkel High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling - results from a randomized, double-blind, and placebo-controlled study Int J Cardiol 146 January (1) 2011 56 63
5. J.G. Cleland, J.J. McMurray, J. Kjekshus, J.H. Cornel, P. Dunselman, and C. Fonseca Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) J Am Coll Cardiol 54 November (20) 2009 1850 1859
6. V. Zacà, S. Rastogi, M. Imai, M. Wang, V.G. Sharov, and A. Jiang Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure J Am Coll Cardiol 50 2007 551 557 (Pubitemid 47126770)
7. D. Tousoulis, I. Andreou, M. Tsiatas, A. Miliou, C. Tentolouris, and G. Siasos Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress Atherosclerosis 214 January (1) 2011 151 157
8. A.C. Diederichsen, J.E. Møller, P. Thayssen, A.B. Junker, L. Videbaek, and S.G. Saekmose Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study - congestive heart failure trial (DanCell-CHF) Eur J Heart Fail 10 July (7) 2008 661 667
9. B.E. Strauer, M. Yousef, and C.M. Schannwell The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study Eur J Heart Fail 12 July (7) 2010 721 729
10. C. Ventura, M. Maioli, Y. Asara, D. Santoni, I. Scarlata, and S. Cantoni Butyric and retinoic mixed ester of hyaluronan. A novel differentiating glycoconjugate affording a high throughput of cardiogenesis in embryonic stem cells J Biol Chem 279 2004 23574 23579 (Pubitemid 38685671)
11. C. Ventura, S. Cantoni, F. Bianchi, V. Lionetti, C. Cavallini, and I. Scarlata Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts J Biol Chem 282 2007 14243 14252 (Pubitemid 47100449)
12. D. Shinmura, I. Togashi, S. Miyoshi, N. Nishiyama, N. Hida, and H. Tsuji Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function Stem Cells 29 2 2011 357 366
13. A. Simioniuc, M. Campan, V. Lionetti, M. Marinelli, G.D. Aquaro, and C. Cavallini Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study Cardiovasc Res 90 3 2011 546 556
14. F. Zemani, J.S. Silvestre, F. Fauvel-Lafeve, A. Bruel, J. Vilar, and I. Bieche Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential Arterioscler Thromb Vasc Biol 28 April (4) 2008 644 650 (Pubitemid 351651342)
15. S.P. Crampton, J. Davis, and C.C. Hughes J Vis Exp 3 2007 183
16. M.W. Pfaffl A new mathematical model for relative quantification in real time PCR Nucleic Acids Res 29 2001 e45
17. A.N. Stratman, A.E. Schwindt, K.M. Malotte, and G.E. Davis Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization Blood 116 22 2010 4720 4730
18. L. Zentilin, U. Puligadda, V. Lionetti, S. Zacchigna, C. Collesi, and L. Pattarini VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction FASEB J 24 May (5) 2010 1467 1478
19. A. Siltanen, K. Kitabayashi, P. Lakkisto, J. Mäkelä, T. Pätilä, and M. Ono hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure PLoS One 6 April (4) 2011 e19161
20. S. Rastogi, M. Guerrero, M. Wang, I. Ilsar, M.S. Sabbah, and R.C. Gupta Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs Am J Physiol Heart Circ Physiol 300 4 2011 H1501 H1509
21. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, and S. Fuchs Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678 685 (Pubitemid 38387752)
22. V. Lionetti, G. Bianchi, F.A. Recchia, and C. Ventura Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure Heart Fail Rev 15 November (6) 2010 531 542
23. J. Waltenberger, L. Claesson-Welsh, A. Siegbahn, M. Shibuya, and C. Heldin Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor J Biol Chem 269 1994 26988 26995 (Pubitemid 24332901)
24. N. Ferrara Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am J Physiol Cell Physiol 280 2001 C1358 C1366
25. K. Maruyama, Y. Mori, S. Murasawa, H. Masaki, N. Takahashi, and Y. Tsutusmi Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases J Mol Cell Cardiol 31 March (3) 1999 607 617 (Pubitemid 29121646)
26. I. Casella, T. Feccia, C. Chelucci, P. Samoggia, G. Castelli, and R. Guerriero Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor Blood 101 February (4) 2003 1316 1323 (Pubitemid 36182501)
27. H.P. Gerber, A.K. Malik, G.P. Solar, D. Sherman, X.H. Liang, and G. Meng VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism Nature 417 Jun (6892) 2002 954 958 (Pubitemid 34716872)
28. M.L. Petreaca, M. Yao, Y. Liu, K. Defea, and M. Martins-Green Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability Mol Biol Cell 18 December (12) 2007 5014 5023 (Pubitemid 350246701)
29. J.S. Yao, W. Zhai, W.L. Young, and G.Y. Yang Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9 Biochem Biophys Res Commun 342 April (4) 2006 1396 1404
30. M.M. Bekhite, A. Finkensieper, S. Binas, J. Müller, R. Wetzker, and H.R. Figulla VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells J Cell Sci 124 June (Pt 11) 2011 1819 1830
31. A.V. Benest, O.A. Stone, W.H. Miller, C.P. Glover, J.B. Uney, and A.H. Baker Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature Arterioscler Thromb Vasc Biol 28 August (8) 2008 1462 1468
32. J. Wang, T. Tokoro, K. Matsui, S. Higa, and I. Kitajima Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells Life Sci 76 March (19) 2005 2257 2268 (Pubitemid 40283650)
33. 2+ channel blocker, increases the endothelial differentiation of endothelial progenitor cells in vitro Hypertens Res 29 December (12) 2006 1047 1054 (Pubitemid 46209917)
34. L. Chu, H. Hao, M. Luo, Y. Huang, Z. Chen, and T. Lu Ox-LDL modifies the behavior of bone marrow stem cells and impairs their endothelial differentiation via inhibition of Akt phosphorylation J Cell Mol Med October 2009 [Epub ahead of print]
35. T. Aoyagi, and T. Matsui Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure Curr Pharm Des June 2011 [Epub ahead of print]
36. B.R. Everaert, E.M. Van Craenenbroeck, V.Y. Hoymans, S.E. Haine, L. Van Nassauw, and V.M. Conraads Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway Int J Cardiol 144 October (3) 2010 350 366
37. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, and M. Tiemann HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 August (3) 2001 391 397 (Pubitemid 32730785)